Programme/Approved Electives for 2025/26
None
Available as a Free Standing Elective
No
The core module ‘Disease Modelling and Therapy’ draws upon the current trends in Regenerative Medicine research by applying translational cell biology for personalised medicine through disease modelling and therapy. The module aims to skill students for a growing market, in response to the growing demand for novel regenerative therapies, fuelled by advances in cell biology, biomaterials, tissue engineering and gene-editing technology. This is a fast-paced area of medicine in the 21st century, that through translational learning and entrepreneurial skills which this module offers, it exposes students to creative ideas for addressing current healthcare needs in the society. The module will combine expertise of academics and stakeholders for training next generation of science entrepreneurs for Regenerative Medicine.
Aims
The module aims to enhance students evidence-based knowledge and to apply their entrepreneurial skills in the fields of disease modelling and therapy for regenerative medicine.
Intended Learning Outcomes
Build and develop entrepreneurial skills for the field of regenerative medicine by participating in module-associated entrepreneurial programme.: 2Apply critical thinking through a business plan for a regenerative medicine application by bringing logical connections of concepts, ideas and skills relevant for this module.: 2Demonstrate understanding of in silico gene engineering for disease modelling through practical training and critically evaluate limitation of approach for the chosen disease.: 1Evaluate the strategies required to develop gene, cell and drug therapy through exemplars.: 1Appraise concepts and advances in disease modelling for regenerative medicine.: 1Assess and critique developments and regulations for disease modelling and therapy for regenerative medicine.: 1,2
Direct contact hours = 60h which consist ofLectures = 15hTutorials = 10hPractical = 5hEntrepreneurship tutorial sessions (with LSC-40145) = 30hIndependent study hours (F4) = 90h which consist ofDirected reading to support lectures/tutorials (including private study) = 40hReport preparation = 25hBusiness Plan preparation = 25h
Students taking this module as optional module, should also take associated module MTE-40028 (Stem Cells) as a supplementary optional module or show proof of knowledge in stem cells at Level 7.
Description of Module Assessment
1: Report weighted 70%Report on disease modelling and therapy in regenerative medicineReport (3000 words) with indicative content to capture
(a) Disease modelling - where students have to apply the practical skills (in silico modelling for
genetic engineering) to a genetic mutation-linked disease of choice and describe aspects of
modelling that disease using stem cells or cancer cells.
(b) Therapy - where students will critically appraise therapy for the same disease, with focus on the advantages, limitations and regulations for cell, gene or drug therapy for that disease.
Report will need to reflect learning from practicals, relevant lecture and tutorials.
2: Presentation weighted 30%Business Plan and PitchGroup work; Business Plan (10%) and Business pitch presentation (20%). Ideas will be developed by the team but individual's contribution will be assessed.
For the Business plan, each team will produce an executive summary (2 A4 pages and a Gantt chart) using a template provided for the mock panel, in advance of their business pitch presentation.
For the Business Pitch presentation to the mock panel (maximum 20 minutes talk by a team), assessment will be based on performance of each team member's contribution to the talk and their response to a random set of predesigned questions.